WTC
KIN

WhitTier Trust Company’s Kindred Biosciences, Inc. KIN Stock Holding History

WhitTier Trust Company’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,000
Closed -$12K – 1007
2020
Q1 		$12K Buy
+3,000
New +$25.5K ﹤0.01% 772

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WhitTier Trust Company's KIN Position: Q2 2020 in Review

WhitTier Trust Company sold out of Kindred Biosciences, Inc. (KIN) in Q2 2020, closing a stake of 3,000 shares — an estimated $12K sold.

WhitTier Trust Company first reported a position in KIN in Q1 2020 and held it in 1 quarter. The position peaked at $12K in Q1 2020. 83 funds tracked by Wall St. Rank hold KIN as of Q2 2020.

  • WhitTier Trust Company reported no remaining Kindred Biosciences, Inc. position as of Q2 2020 after selling out during the quarter.
  • WhitTier Trust Company sold 3,000 Kindred Biosciences, Inc. shares in Q2 2020, an estimated $12K.
  • WhitTier Trust Company first reported a position in Kindred Biosciences, Inc. in Q1 2020 and held it in 1 quarter.
  • WhitTier Trust Company's Kindred Biosciences, Inc. position peaked at $12K in Q1 2020.
  • 83 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2020.

Based on WhitTier Trust Company's 13F filing for Q2 2020, filed 10 Jul 2020.